Pharmacoproteomic Identifies Kinase Pathways in Hepatocellular Carcinoma That Drive

Shao-En Ong

doi:10.4172/jcmp.1000117

Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication
J Cell Mol Pharmacol 2022, Vol 6(2): 117
DOI: 10.4172/jcmp.1000117

Pharmacoproteomic Identifies Kinase Pathways in Hepatocellular Carcinoma That Drive

Shao-En Ong^*: Department of Pharmacology, University of Washington, Seattle, WA 98195, USA

^*Corresponding Author : Shao-En Ong, Department of Pharmacology, University of Washington, Seattle, WA 98195, USA, Email: shaoen@u.washington.edu

Received Date: Apr 04, 2022 / Published Date: May 28, 2022

View PDF Download PDF

Citation: Ong SE (2022) Pharmacoproteomic Identifies Kinase Pathways in Hepatocellular Carcinoma That Drive. J Cell Mol Pharmacol 6: 117. Doi: 10.4172/jcmp.1000117

Copyright: © 2022 Ong SE. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.